國瑞健康:澄清公布
Glory Health Industry Shrinks Loss in 2023
Glory Health Industry (HKG:2329) recorded a decline in attributable loss for the year ended Dec. 31, 2023, to 564 million yuan from 912.8 million yuan in 2022, a Tuesday filing on the Hong Kong bourse
GLORY HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31,2023
Guorui Health (02329) announced 2023 results. Losses attributable to owners of about 564 million yuan narrowed by 38.2% year-on-year
According to the Zhitong Finance App, Guorui Health (02329) announced its 2023 results, with total revenue of about 2.506 billion yuan, a year-on-year decrease of 35.8%; loss attributable to company owners was about 564 million yuan, a year-on-year decrease of 38.2%; loss per share was 0.13 points. According to the announcement, the decrease in revenue during the reporting period was mainly due to a reduction in the completed delivery area of the property development sector and a decrease in sales.
GLORY HEALTH: Annual Report
Guorui Health (02329.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Guorui Health (02329.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Guorui Health [02329] now reports HK$0.025, a decrease of 10.71%
As of 09:30 Guorui Health [02329] reported HK$0.025, down HK$0.003 or 10.71% from yesterday's closing price, with a turnover of HK$0.03 million, today's high of HK$0.025 and a low price of HK$0.025. Based on yesterday's closing price, the 10-day average price was HK$0.03, and the 50-day average price was HK$0.03. The current price-earnings ratio was -0.12 times, and the 14-day strength and weakness index reported 32.14.
Guorui Health (02329.HK) appoints Lam Yuen-ling as company secretary and Hong Kong representative for receiving legal process documents
Glonghui, Feb. 8 | Guorui Health (02329.HK) announced that from February 7, 2024, Lam Yuen-ling has been appointed as the company secretary and authorized representative to receive and deliver legal process documents and notices in Hong Kong on behalf of the company in accordance with Part 16 of the Companies Ordinance, Chapter 622 of the Laws of Hong Kong.
Guorui Health [02329] now reports HK$0.027, an increase of 17.39%
As of 14:11, Guorui Health [02329] reported HK$0.027, up HK$0.004 or 17.39% from yesterday's closing price, with a turnover of HK$22,900. Today's high price was HK$0.027 and the lowest price was HK$0.023. Based on yesterday's closing price, the 10-day average price was HK$0.03, and the 50-day average price was HK$0.03. The current price-earnings ratio was -0.10 times, and the 14-day strength and weakness index reported 17.39.
Guorui Health (02329) fell 15.40% to 0.022 yuan, hitting a 52-week low
As of 16:08, Guorui Health (02329) fell 15.40% from yesterday's closing price and is now reporting a 52-week low of $0.022; the trading volume is 2,425 million shares, with a turnover of HK$54,000.
Guorui Health (02329): Zhao Yuhong was appointed as Executive Director
Guorui Health (02329) announced that Dong Xueer, Hao Zhenhe, and Sun Xiaodong each intended to invest more time and energy...
Guorui Health (02329.HK) appoints Ming dynasty accountants as new auditors
Gelonghui, January 12 | Guorui Health (02329.HK) announced that the company has appointed an accountant from the Ming dynasty as the company's new auditor, effective January 12, 2024 to fill the vacancy at Dahua Ma Shiyun Certified Public Accountants Limited after his retirement. The term of office will end until the end of the next annual general meeting of shareholders of the company.
Guorui Health [02329] is now reported at HK$0.029, a decrease of 14.71%
As of 15:56 Guorui Health [02329] reported HK$0.029, down HK$0.005 or 14.71% from yesterday's closing price of HK$0.034, with a turnover of HK$0.83 million, today's highest price of HK$0.034, and the lowest price of HK$0.031. Based on yesterday's closing price, the 10-day average price is HK$0.03 and the 50-day average price is HK$0.06. The current price-earnings ratio is -0.15 times. The 14-day strength index is 43.18.
Guorui Health [02329] is now reported at HK$0.031, a decrease of 13.89%
As of 14:50 Guorui Health [02329] reported HK$0.031, down HK$0.005 or 13.89% from yesterday's closing price of HK$0.036, with a turnover of HK$0.00 million, today's highest price of HK$0.031, and the lowest price of HK$0.031. Based on yesterday's closing price, the 10-day average price is HK$0.03 and the 50-day average price is HK$0.06. The current price-earnings ratio is -0.16 times. The 14-day strength index is 41.86.
Guorui Health: Dahua Ma Shiyun Certified Public Accountants resigns as auditor
Guorui Health (02329) announced that Dahuama Shiyun Certified Public Accountants Co., Ltd. has submitted its resignation as the company's auditor, effective November 28, 2023.
GLORY HEALTH: INTERIM REPORT 2023
Guorui Health (02329) released interim results. Loss attributable to shareholders of 267 million yuan decreased by 60.9% year-on-year
According to Zhitong Financial App, Guorui Health (02329) announced its interim results for the six months ended June 30, 2023. The group achieved total revenue of RMB 1,457 million (same unit below), a year-on-year decrease of 50.55%; losses attributable to company owners were 267 million yuan, a year-on-year decrease of 60.9%; and losses of 6 points per share. The contracted sales volume for the six months ended June 30, 2023 was 2,087 billion yuan, and the corresponding contracted construction area was about 165,900 square meters. The average sales price of signed contracts during the reporting period was 27875.3 yuan per square meter. As of 2023/6/3
GLORY HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
GLORY HEALTH: DATE OF BOARD MEETING
Guorui Health (02329): The maturity date of the loan of 1,333 million yuan invested by Guorui Industrial was extended until April 8, 2025
According to the Zhitong Finance App, Guorui Health (02329) issued an announcement regarding the extension of several loan maturities of Guorui Industrial (Beijing) Investment Co., Ltd. (Guorui Industrial Investment), a subsidiary of the company. Guorui Industrial Investment signed a loan rollover agreement with the Beijing branch of Bank of Tianjin Co., Ltd. to extend the loan maturity date of previously signed loan contracts totaling RMB 1,333 billion from October 9, 2023 to April 8, 2025. The company continues to be jointly and severally liable for these loans. The loan rollover matter was reviewed and approved by the board of directors on June 9, 2023
No Data